Table 3.

Serial change in FPG during the study period

Time point	Empagliflozin (n = 154), mg/dL	Insulin (n = 147), mg/dL	P value
Baseline	186.5 ± 49.9	190.3 ± 73.6	NS
Month 3	118 ± 22.8	135 ± 40.2	< 0.01
Month 6	125.6 ± 31.8	138.4 ± 51.1	< 0.05
Month 12	127.3 ± 30.0	136.3 ± 43.1	NS
Month 18	126.0 ± 30.4	134.7 ± 51.1	NS
Month 24	130.8 ± 28.3	130.8 ± 47.2	NS
Month 30	129.4 ± 23.6	144.0 ± 72.8	NS
Month 36	128.7 ± 24.8	131.4 ± 69.3	NS

Data are expressed as mean ± (SD). For tests of between-group differences, the paired t-test was performed at each time point. P values are expressed as either < 0.05, < 0.01, or NS (non-significant)